A carregar...

Bad Company: Microenvironmentally Mediated Resistance to Targeted Therapy in Melanoma

This review will focus on the role of the tumor microenvironment (TME) in the development of drug resistance in melanoma. Resistance to mitogen-activated protein kinase inhibitors (MAPKi) in melanoma is observed months after treatment, a phenomenon that is often attributed to the incredible plastici...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pigment Cell Melanoma Res
Main Authors: Almeida, Filipe V, Douglass, Stephen M., Fane, Mitchell E., Weeraratna, Ashani T.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727967/
https://ncbi.nlm.nih.gov/pubmed/30216694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pcmr.12736
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!